Most Read News


Expanded implementation of ‘Mobile HealthCare’ from May

The Ministry of Health and Welfare(Ministry Jin-Yup Jung, MOHW) announced the drastic expansion of ‘Mobile HealthCare’ which allows people(not patients) who have a high risk of getting chronic diseases to manage their...

It is ‘good or bad’ to introduce products from multinational pharmas?

CEOs of pharmaceutical company have had different viewpoints over introduced products(merchandise) since the co-marketing between Korean pharmaceutical companies and multinational pharmaceutical companies(Korean pharm...

No. of Korean drugs approved in U.S. and Europe exceeds double digit

The number of Korean pharmaceutical drugs which acquired sales approval in medically advanced countries, such as the U.S. and Europe, has exceeded a double digit. According to the recent pharmaceutical industry, Kore...

What are strategic considerations for IPR in U.S. pharmaceutical and biotechnology fields?

A filing procedure, called Inter Partes Review(IPR), conducted to review the patentability in a technology patent registered in the U.S. pharmaceutical and biotechnology market, is conducted by a law body of the U.S. ...

MFDS designates renal cell carcinoma therapy ‘cabozantinib’ as orphan drug

‘Cabozantinib,’ a progressive renal cell carcinoma treatment, will be designated as orphan drug. The Ministry of Food and Drug Safety(MFDS) will make a pre-announcement of the ‘Partial Amendment to the Regulation for...

Rumors about next chairman of KPMA while Former Rep. Hui-Mok Won rises

While there are a lot of advance rumors about who will be the next chairman as Korea Pharmaceutical Manufacturers Association(KPMA) Chairman Kyung-Ho Lee expressed resignation remaining a year left for the end of offi...

MOHW to decide restriction on Novartis’ insurance benefits within February

Novartis, which has been suspected of providing KRW 2.6 billion rebates, will get a measure of restriction on the health insurance benefit. The Ministry of Health and Welfare(MOHW) announced the Ministry of Food and ...

“Artificial tears and antidiarrheals should be added as emergency household drug”

The Ministry of Health and Welfare(MOHW) will actively start to review the adjustment of items for emergency household products. On the 24th, the MOHW(Ministry JinYup Jung) revealed the result of the outsourced resea...

First and only bladder cancer immunotherapy ‘TECENTRIQ’ acquires approval from MFDS

Roche Korea(GM Matt Sause) announced acquisition of approval of TECENTRIQ(atezolizumab), the first and only anti-PDL1 cancer immunotherapy, on the 12th of January as a secondary treatment from the Ministry of Food and...

‘Things to know’ about newly-adjusted pharma industry policies in 2017

While the cycle for drug price cuts will be adjusted from a year to 2 years from this year, punishment for drug rebates will be tightened. Moreover, sellers of shortage-prevented drugs for less than 91% of their uppe...

Biobetter jointly developed with Ildong, ‘ublituximab’ completed part 1 of Phase 2 clinical trial

The development of ‘ublituximab(TG-1101),’ a TG Therapeutics’ monoclonal antibody biobetter, jointly conducted with Ildong Pharmaceutical(CEO Woong-Seup Yoon), passed the part 1 of the Phase 2 clinical trial in the U....

Celltrion’s Truxima wins all the patent nullification trials in Korea

Celltrion announced the Intellectual Property Tribunal ruled nullification of the patent for the chronic lymphocytic leukemia(CLL) indication owned by Bio-Gen, which is related to the patent of Rituxan, the original p...

Ignorance lets Tylenol be recommended for headache after alcohol consumption

The Korean Pharmaceutical Association(President Chan-Hwi Cho) announced on the 25th how well stores selling emergency household products follow the relevant regulation. According to the announcement, 215 of the 300 s...

Medical, pharmaceutical civic organizations participates in Korean Medicine Revising Campaign

The pharmaceutical distribution industry has attracted attention as deciding to start the Korean Medicine Reviving Campaign Headquarters participated by the medical field, pharmaceutical industry and non-governmental ...

Large convenient stores made KRW 32 billion sales for emergency household drugs

The top sales emergency household drug was Tylenol 500mg. According to the analysis result of the 2015 Sales Report of the Top 4 Convenient Stores, based on the ‘Research Report for the Status of the Emergency Househ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.